Pluri Congratulates Mesoblast on FDA Approval of First Mesenchymal Stromal Cell Therapy for Steroid-Refractory Acute Graft-Versus-Host Disease
Pluri祝贺Mesoblast获得FDA对首个针对类固醇难治急性移植物抗宿主病的间充质基质细胞治疗的批准
Pluri Congratulates Mesoblast on FDA Approval of First Mesenchymal Stromal Cell Therapy for Steroid-Refractory Acute Graft-Versus-Host Disease
Pluri祝贺Mesoblast获得FDA对首个针对类固醇难治急性移植物抗宿主病的间充质基质细胞治疗的批准
使用浏览器的分享功能,分享给你的好友吧